ARG Forms Rare Disease Advisory Board

Aug 10, 2017
By Applied Clinical Trials Editors

Atlantic Research Group, Inc. (ARG)—a rare disease-focused contract research organization (CRO)—announced that it formed its rare disease strategic advisory board (SAB). The SAB will consist of outside scientific experts, patient advocates, and former executives from rare disease-focused biotechs. 

Read the full release here.

 

native1_300x100
lorem ipsum